Dr. Uitto’s representative experience includes:
- Advising on early stage platform and discovery stage patent strategies for several pharmaceutical and biological therapeutic companies
- Leading IP due diligence for various pharmaceutical and life science companies in regards to licensing or acquiring programs and product candidates
- Representing underwriters during initial public offerings and follow-on offerings for AC Immune, Arvinas, Beigene, BeyondSpring Pharmaceuticals, Inc., InFlaRx, Orchard Therapeutics, and ArgenX
Before joining Goodwin, Dr. Uitto was General Counsel of Numira Biosciences.